Evidence map›Paper›PMID 33353888›Full record

ArticleAging2020

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests.

Biagio Cangiano, Letizia Maria Fatti, Leila Danesi, Giacomo Gazzano, Marina Croci, Giovanni Vitale, Luisa Gilardini, Stefania Bonadonna, Iacopo Chiodini, Chiara Francesca Caparello and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 7 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 7 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Vitamin D-A prominent immunomodulator to prevent COVID-19 infection.International journal of rheumatic diseases · 2023
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Biagio CangianoIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Letizia Maria FattiIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Leila DanesiIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Giacomo GazzanoIRCCS Istituto Auxologico Italiano, Anatomic Pathology Unit, Milan, Italy.
Marina CrociIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Giovanni VitaleIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Luisa GilardiniIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Stefania BonadonnaIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Iacopo ChiodiniIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Chiara Francesca CaparelloIRCCS Istituto Auxologico Italiano, Gastroenterology and Digestive Endoscopy, Milan, Italy.
Antonio ContiIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Luca PersaniIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
Marco Stramba-BadialeIRCCS Istituto Auxologico Italiano, Department of Geriatrics and Cardiovascular Medicine, Milan, Italy.
Marco BonomiIRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, Milan, Italy.
IRCCS Istituto Auxologico Italiano · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic caused an increased mortality in nursing homes due to its quick spread and the age-related high lethality.

resultsWe observed a two-month mortality of 40%, compared to 6.4% in the previous year. This increase was seen in both COVID-19 positive (43%) and negative (24%) residents, but 8 patients among those testing negative on the swab, tested positive on serological tests. Increased mortality was associated with male gender, older age, no previous vitamin D supplementation and worse "activities of daily living (ADL)" scores, such as Barthel index, Tinetti scale and S.OS.I.A. CLASSIFICATION:

conclusionOur data confirms a higher geriatric mortality due to COVID-19. Negative residents also had higher mortality, which we suspect is secondary to preanalytical error and a low sensitivity of the swab test in poorly compliant subjects. Male gender, older age and low scores on ADL scales (probably due to immobility) are risk factors for COVID-19 related mortality. Finally, mortality was inversely associated with vitamin D supplementation.

designIn this observational study, we described the two-month mortality among the 157 residents (age 60-100) of a nursing home after Sars-CoV-2 spreading, reporting the factors associated with the outcome. We also compared the diagnostic tests for Sars-CoV-2.

Indexed as

Nursing HomesSARS-CoV-2Activities of Daily LivingAgedAged, 80 and overAge FactorsCOVID-19Dietary SupplementsFemaleHumansItalyMaleMiddle AgedMortalityPandemicsSensitivity and SpecificityVitamin Dactivities of daily livingCOVID-19hydroxychloroquinenasopharyngeal swabsensitivity and specificityserology

Identifiers

PMID33353888
PMCPMC7803543
OpenAlexW3114008597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.